Select Ongoing Trials Currently Enrolling Patients with Melanoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 28
- Publication type:
- Article
Works matching IS 21644403 AND DT 2022 AND VI 12 AND IP 1
Results: 28
1
2
Introducing Genmab: Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment.
- Published in:
- 2022
- By:
- Publication type:
- Interview
3
Preparing for the End of the PHE: What Practices Can Do Now.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 24
- By:
- Publication type:
- Article
4
Best Practices for Genetic Cancer Risk Assessment and Counseling.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 22
- By:
- Publication type:
- Article
5
Adjuvant Pembrolizumab Maintains DFS Benefit in Patients with High-Risk RCC.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 19
- By:
- Publication type:
- Article
6
First-Line Treatment with Olaparib plus Abiraterone Improves Outcomes in Patients with CRPC Regardless of HRR Mutational Status.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 17
- By:
- Publication type:
- Article
7
A Path Toward Clinical Trial Diversity.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 15
- By:
- Publication type:
- Article
8
Genetic Score Makes PSA Screening More Accurate.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 8
- By:
- Publication type:
- Article
9
Collaboration Among Oncologists and Primary Care Physicians Is Key to Closing the “Black Hole” in Cancer Survivorship Care.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 7
- By:
- Publication type:
- Article
10
Experts Discuss the Evolving Role of Telemedicine in Oncology Care.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
11
Can We Bring Back Common Sense When Discussing Value in Healthcare?
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
12
Sotorasib Shows Long-Term Efficacy in Metastatic NSCLC with KRAS Mutation.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
13
Cytalux, a Novel Imaging Agent, FDA Approved for Diagnosing Inoperable Ovarian Cancer Lesions.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 34
- Publication type:
- Article
14
FDA Approves Regimen of Darzalex Faspro, Kyprolis, and Dexamethasone for Relapsed or Refractory Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 34
- Publication type:
- Article
15
Adjuvant Pembrolizumab Approved for Stage IIB or IIC Melanoma Following Complete Resection.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 33
- Publication type:
- Article
16
Orencia First Drug Approved for Prevention of Acute Graft-versus-Host Disease.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 33
- Publication type:
- Article
17
Molecular Epidemiology of Cholangiocarcinoma: Identifying New Inherited Variants.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 32
- By:
- Publication type:
- Article
18
Abiraterone Added to ADT Improves Survival in Patients with High-Risk Prostate Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 29
- By:
- Publication type:
- Article
19
Adagrasib Shows Encouraging Activity in Select Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 28
- By:
- Publication type:
- Article
20
Refining Your Leadership Posture by Setting the Tone for Your Organization.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 26
- By:
- Publication type:
- Article
21
Mosunetuzumab Induces Deep Remissions in Relapsed/Refractory Follicular Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 24
- By:
- Publication type:
- Article
22
Results from 2 Studies Provide Insights on Antibody Response to COVID-19 Vaccines in Patients with Hematologic Malignancies.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 22
- By:
- Publication type:
- Article
23
Stakeholders Discuss Opportunities and Challenges in Biosimilars Adoption.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 16
- By:
- Publication type:
- Article
24
The Current and Future State of Medically Integrated Pharmacy in Oncology.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 14
- By:
- Publication type:
- Article
25
Flexibility and Adaption Key for Future-Proofing Cancer Care Against Pandemics.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 12
- By:
- Publication type:
- Article
26
Reducing Racial Disparities in Cancer Care.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
27
Trastuzumab Deruxtecan Shows Promise in Controlling Stable Brain Metastases in HER2-Positive Breast Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
28
CAR T-Cell Therapies Demonstrate Efficacy in Second-Line Treatment of LBCL.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article